1. Home
  2. ASLE vs DCTH Comparison

ASLE vs DCTH Comparison

Compare ASLE & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AerSale Corporation

ASLE

AerSale Corporation

HOLD

Current Price

$6.83

Market Cap

299.0M

ML Signal

HOLD

Logo Delcath Systems Inc.

DCTH

Delcath Systems Inc.

HOLD

Current Price

$10.62

Market Cap

311.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASLE
DCTH
Founded
2008
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
299.0M
311.7M
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
ASLE
DCTH
Price
$6.83
$10.62
Analyst Decision
Hold
Strong Buy
Analyst Count
2
4
Target Price
$7.00
$22.00
AVG Volume (30 Days)
205.7K
264.9K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
63.64
107.53
EPS
0.18
0.07
Revenue
$335,286,000.00
N/A
Revenue This Year
$23.41
$24.54
Revenue Next Year
$6.80
$33.15
P/E Ratio
$38.00
$155.14
Revenue Growth
N/A
N/A
52 Week Low
$5.56
$8.12
52 Week High
$9.08
$18.23

Technical Indicators

Market Signals
Indicator
ASLE
DCTH
Relative Strength Index (RSI) 54.05 57.05
Support Level $5.92 $10.50
Resistance Level $7.16 $10.75
Average True Range (ATR) 0.20 0.37
MACD 0.03 0.00
Stochastic Oscillator 57.25 62.91

Price Performance

Historical Comparison
ASLE
DCTH

About ASLE AerSale Corporation

AerSale Corp offers full-service support to owners and operators of mid-life commercial aircraft. It specializes in the sale, lease, and exchange of used aircraft, engines, and components, in addition to providing various maintenance, repair, and overhaul, and engineering services for commercial aircraft and components. AerSale also offers asset management services to owners of end-of-life aircraft and engine portfolios. The company has two reportable segments: Asset Management Solutions and TechOps. Maximum revenue is generated from the Asset Management Solutions segment, which comprises activities to extract value from strategic asset acquisitions through leasing, trading, or disassembling for product sales. Geographically, the company derives maximum revenue from its domestic market.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: